ePrints

The consequences of ‘Brexit’ for drug discovery and development, and the regulatory implications

Lookup NU author(s): Emeritus Professor Bernard Golding, Professor Mike Waring

Downloads

• Accepted version [.pdf]

Licence

This is the authors' accepted manuscript of an article that has been published in its final definitive form by Taylor and Francis Ltd, 2018.

For re-use rights please refer to the publisher's terms and conditions.

Publication metadata

Author(s): Golding BT, Waring MJ

Publication type: Article

Publication status: Published

Journal: Expert Opinion on Drug Discovery

Year: 2018

Volume: 13

Issue: 7

Pages: 583-585

Print publication date: 01/07/2018

Online publication date: 10/04/2018

Acceptance date: 06/04/2018

Date deposited: 06/06/2018

ISSN (print): 1746-0441

ISSN (electronic): 1746-045X

Publisher: Taylor and Francis Ltd

URL: https://doi.org/10.1080/17460441.2018.1463215

DOI: 10.1080/17460441.2018.1463215

Altmetrics

Share